“…It should be noticed that while numerous synthetic approaches to 5-hydroxy-3-pyrrolin-2-one derivatives have been reported [ 7 , 8 , 9 , 10 , 11 , 12 ], to our best knowledge, to date, there are just a few methods leading to 3,5-diaryl substituted γ-hydroxy butyrolactams 1 [ 1 , 13 , 14 ], and none that would afford the herein-described 3,5-di-aryl/heteroaryl-4-benzyl pattern. Thus, the developed procedures greatly expand the chemical space [ 15 ] of available 5-hydroxy 3-pyrrolin-2-ones which, in turn, could be used among other things for a convenient access to other heterocyclic systems [ 16 ].…”